CBD: Regulatory blues continue, but hope reigns eternal
As for CBD, it’s been another frustrating year for advocates with no progress on a regulatory path forward at the federal level and indications in a recent flurry of warning letters that the FDA is taking a harder line on cannabinoids in foods and beverages.
Image credit: Getty Images-24K-Production
